Clinical protocol
RTOG 0813 protocol — SBRT for centrally located NSCLC
NRG Oncology / RTOG
DoseLab summary
NRG Oncology's protocol page for RTOG 0813, with the protocol document and supporting forms. Read the trial's own dose constraints, its definition of a central tumor and its plan-evaluation requirements in the protocol document. Results are published separately as the RTOG 0813 trial report.
Why this is useful
Go here when a plan follows this trial's five-fraction central schedule: read its normal-tissue limits, target definitions and plan-evaluation requirements in the protocol document itself rather than second-hand.
Reference details
- Title
- RTOG 0813 protocol — SBRT for centrally located NSCLC
- Authors / organization
- NRG Oncology / RTOG
- Publication / protocol
- Protocol document, RTOG 0813
- Version
- Version dated 2015-06-08 (per the NRG protocol page)
- Year
- Pending verification
- DOI
- Pending verification
- Disease sites
- Lung
- Topics
- Dose Constraints, SBRT, Protocols, RTOG, NRG, Central tumors
- Fractionation context
- SBRT, 5 fractions
- Last reviewed by DoseLab
- Pending verification